Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling

Genes, Brain and Behavior

Volumn 8, Issue 2, 2009, Pages 203-211

  Kamprath, K ^a,b   Plendl, W ^a   Marsicano, G ^c,d   Deussing, J M ^a   Wurst, W ^e   Lutz, B ^f   Wotjak, C T ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c INSTITUT FRANÇOIS MAGENDIE   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

CB 1; Corticosterone; CRF; CRH; Endocannabinoids; Extinction; HPA axis; Rimonabant; SR141716; Stress

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; ENDOCANNABINOID; GLUTAMATE RECEPTOR; RIMONABANT;

ADAPTIVE BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEAR; FOOTSHOCK; FOREBRAIN; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION;

ACOUSTIC STIMULATION; ADAPTATION, PSYCHOLOGICAL; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; ELECTROSHOCK; ENDOCANNABINOIDS; FEAR; GLUTAMATES; MALE; MICE; MICE, KNOCKOUT; NEURONS; PIPERIDINES; PROSENCEPHALON; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, GLUTAMATE; SIGNAL TRANSDUCTION;

MUS;

EID: 61449264779     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2008.00463.x     Document Type: Article

References (48)

1. Armario, A., Montero, J.L. Balasch, J 1986) Sensitivity of corticosterone and some metabolic variables to graded levels of low intensity stresses in adult male rats. Physiol Behav 37, 559 561.
2. Bale, T.L. Vale, W.W 2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44, 525 557.
3. Bale, T.L., Contarino, A., Smith, G.W., Chan, R., Gold, L.H., Sawchenko, P.E., Koob, G.F., Vale, W.W. Lee, K.F 2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24, 410 414.
4. Cai, W.H., Blundell, J., Han, J., Greene, R.W. Powell, C.M 2006) Postreactivation glucocorticoids impair recall of established fear memory. J Neurosci 26, 9560 9566.
5. Chhatwal, J.P., Davis, M., Maguschak, K.A. Ressler, K.J 2005) Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 30, 516 524.
6. Coste, S.C., Kesterson, R.A., Heldwein, K.A., Stevens, S.L., Heard, A.D., Hollis, J.H., Murray, S.E., Hill, J.K., Pantely, G.A., Hohimer, A.R., Hatton, D.C., Phillips, T.J., Finn, D.A., Low, M.J., Rittenberg, M.B., Stenzel, P. Stenzel-Poore, M.P 2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24, 403 409.
7. Cota, D., Marsicano, G., Tschop, M., Grubler, Y., Flachskamm, C., Schubert, M., Auer, D., Yassouridis, A., Thone-Reineke, C., Ortmann, S., Tomassoni, F., Cervino, C., Nisoli, E., Linthorst, A.C., Pasquali, R., Lutz, B., Stalla, G.K. Pagotto, U 2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112, 423 431.
8. Cota, D., Steiner, M.A., Marsicano, G., Cervino, C., Herman, J.P., Grubler, Y., Stalla, J., Pasquali, R., Lutz, B., Stalla, G.K. Pagotto, U 2007) Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 148, 1574 1581.
9. Di, S., Malcher-Lopes, R., Halmos, K.C. Tasker, J.G 2003) Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23, 4850 4857.
10. Di, S., Boudaba, C., Popescu, I.R., Weng, F.J., Harris, C., Marcheselli, V.L., Bazan, N.G. Tasker, J.G 2005a) Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J Physiol 569, 751 760.
11. Di, S., Malcher-Lopes, R., Marcheselli, V.L., Bazan, N.G. Tasker, J.G 2005b) Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 146, 4292 4301.
12. Haller, J., Varga, B., Ledent, C., Barna, I. Freund, T.F 2004) Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 19, 1906 1912.
13. Haring, M., Marsicano, G., Lutz, B. Monory, K 2007) Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 146, 1212 1219.
14. Hennessy, M.B. Levine, S 1978) Sensitive pituitary-adrenal responsiveness to varying intensities of psychological stimulation. Physiol Behav 21, 295 297.
15. Hennessy, M.B., Heybach, J.P., Vernikos, J. Levine, S 1979) Plasma corticosterone concentrations sensitively reflect levels of stimulus intensity in the rat. Physiol Behav 22, 821 825.
16. Hermann, H. Lutz, B 2005) Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain. Neurosci Lett 375, 13 18.
17. Herry, C., Bach, D.R., Esposito, F., Di Salle, F., Perrig, W.J., Scheffler, K., Luthi, A. Seifritz, E 2007) Processing of temporal unpredictability in human and animal amygdala. J Neurosci 27, 5958 5966.
18. Kamprath, K. Wotjak, C.T 2004) Nonassociative learning processes determine expression and extinction of conditioned fear in mice. Learn Mem 11, 770 786.
19. Kamprath, K., Marsicano, G., Tang, J., Monory, K., Bisogno, T., Di Marzo, V., Lutz, B. Wotjak, C.T 2006) Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci 26, 6677 6686.
20. Kavushansky, A., Vouimba, R.M., Cohen, H. Richter-Levin, G 2006) Activity and plasticity in the CA1, the dentate gyrus, and the amygdala following controllable vs. uncontrollable water stress. Hippocampus 16, 35 42.
21. Keck, M.E., Ohl, F., Holsboer, F. Muller, M.B 2005) Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci Biobehav Rev 29, 867 889.
22. Kishimoto, T., Radulovic, J., Radulovic, M., Lin, C.R., Schrick, C., Hooshmand, F., Hermanson, O., Rosenfeld, M.G. Spiess, J 2000) Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 24, 415 419.
23. Marsicano, G. Kuner, R 2008) Anatomical distribution of receptors, ligands and enzymes in the brain and in the spinal cord. Circuitries and neurochemistry. In Köfalvi, A ed Cannabinoids and the Brain. Springer, New York, pp. 161 201.
24. Marsicano, G. Lutz, B 1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11, 4213 4225.
25. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di Marzo, V. Lutz, B 2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418, 530 534.
26. Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S.C., Cascio, M.G., Gutierrez, S.O., van der, S.M., Lopez-Rodriguez, M.L., Casanova, E., Schutz, G., Zieglgansberger, W., Di Marzo, V., Behl, C. Lutz, B 2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84 88.
27. Millan, M.J 2003) The neurobiology and control of anxious states. Prog Neurobiol 70, 83 244.
28. Moghaddam, B 2002) Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry 51, 775 787.
29. Monory, K., Massa, F., Egertova, M. et al 2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51, 455 466.
30. Monory, K., Blaudzun, H., Massa, F., Kaiser, N., Lemberger, T., Schutz, G., Wotjak, C.T., Lutz, B. Marsicano, G 2007) Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biol 5, e269.
31. Moreira, F.A., Kaiser, N., Monory, K. Lutz, B 2008) Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54, 141 150.
32. Muller, M.B., Landgraf, R., Preil, J., Sillaber, I., Kresse, A.E., Keck, M.E., Zimmermann, S., Holsboer, F., Wurst, W 2000) Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids. Endocrinology 141, 4262 4269.
33. Naidu, P.S., Varvel, S.A., Ahn, K., Cravatt, B.F., Martin, B.R. Lichtman, A.H 2007) Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology (Berl) 192 (1 61 70.
34. Nordquist, R.E., Steckler, T., Wettstein, J.G., Mackie, C. Spooren, W 2008) Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety. Psychopharmacology (Berl) 199, 389 402.
35. Patel, S. Hillard, C.J 2008) Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci 27, 2821 2829.
36. Patel, S., Roelke, C.T., Rademacher, D.J. Hillard, C.J 2005) Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur J Neurosci 21, 1057 1069.
37. Petitet, F., Jeantaud, B., Bertrand, P. Imperato, A 1999) Cannabinoid penetration into mouse brain as determined by ex vivo binding. Eur J Pharmacol 374, 417 421.
38. Piomelli, D 2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4, 873 884.
39. Rademacher, D.J., Meier, S.E., Shi, L., Ho, W.S., Jarrahian, A. Hillard, C.J 2008) Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 54, 108 116.
40. Radulovic, J., Ruhmann, A., Liepold, T. Spiess, J 1999) Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 19, 5016 5025.
41. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G. Caput, D. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350, 240 244.
42. Skorzewska, A., Bidzinski, A., Lehner, M., Turzynska, D., Sobolewska, A., Hamed, A., Szyndler, J., Maciejak, P. Plaznik, A 2007) The effects of acute corticosterone administration on anxiety, endogenous corticosterone, and c-Fos expression in the rat brain. Horm Behav 52, 317 325.
43. Steckler, T. Holsboer, F 1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46, 1480 1508.
44. Steiner, M.A., Marsicano, G., Nestler, E.J., Holsboer, F., Lutz, B. Wotjak, C.T 2008a) Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 33, 54 67.
45. Steiner, M.A., Marsicano, G., Wotjak, C.T. Lutz, B 2008b) Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 33, 1165 1170.
46. Suzuki, A., Josselyn, S.A., Frankland, P.W., Masushige, S., Silva, A.J. Kida, S 2004) Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 24, 4787 4795.
47. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J.M., Stalla, G.K., Blanquet, V., Steckler, T., Holsboer, F. Wurst, W 1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin- releasing hormone receptor 1. Nat Genet 19, 162 166.
48. Wilson, R.I. Nicoll, R.A 2002) Endocannabinoid signaling in the brain. Science 296, 678 682.